Prometheus Biosciences
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Prometheus Biosciences's balance sheet done over the years? Its assets were worth $740,773,000 last year, which is more than in the previous period. 9% of Prometheus Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $64,805,000, which means an increase by 29% compared compared to last year.
Debt to Assets
| 2016 | 144914000 | 50.14M | 34.6% |
|---|---|---|---|
| 2022 | 740773000 | 64.80M | 8.75% |
RXDX Balance Sheet (2017 – 2023)
| 2023 | 2017 | |
|---|---|---|
Assets | ||
Current assets: | ||
Cash and cash equivalents | 292.42M | 24.34M |
Short term investments | 403.32M | 83.63M |
Net receivables | 1.02M | 0 |
Inventory | -1.02M | 0 |
Other current assets | 12.39M | 3.87M |
Total current assets | 708.15M | 111.85M |
Non-current assets: | ||
Property, Plant and Equipment | 31.65M | 6.27M |
Goodwill | 0 | 0 |
Intangible assets | 0 | 0 |
Long term investments | 0 | 0 |
Other non-current assets | 971K | 26.79M |
Total non-current assets | 32.62M | 33.06M |
Total assets | 740.77M | 144.91M |
Liabilities | ||
| Current liabilities: | ||
Accounts payable | ||
Deferred revenue | 1.29M | 0 |
Short term debt | 3.21M | 0 |
Total current liabilities | 22.81M | 17.51M |
| Non-current liabilities: | ||
Long term debt | 26.32M | 31.11M |
Deferred tax | 0 | 0 |
Other non-current liabilities | 41.98M | 1.51M |
Total non-current liabilities | 41.98M | 32.62M |
Total liabilities | 64.80M | 50.14M |
| Data source | Data source |